540 related articles for article (PubMed ID: 28441991)
21. Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses.
Gauvreau GM; Arm JP; Boulet LP; Leigh R; Cockcroft DW; Davis BE; Mayers I; FitzGerald JM; Dahlen B; Killian KJ; Laviolette M; Carlsten C; Lazarinis N; Watson RM; Milot J; Swystun V; Bowen M; Hui L; Lantz AS; Meiser K; Maahs S; Lowe PJ; Skerjanec A; Drollmann A; O'Byrne PM
J Allergy Clin Immunol; 2016 Oct; 138(4):1051-1059. PubMed ID: 27185571
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal study of the expression of FcεRI and IgE on basophils and dendritic cells in association with basophil function in two patients with severe allergic asthma treated with Omalizumab.
Pereira Santos MC; Campos Melo A; Caetano A; Caiado J; Mendes A; Pereira Barbosa M; Branco Ferreira M
Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):38-40. PubMed ID: 25781192
[TBL] [Abstract][Full Text] [Related]
23. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors.
Lichtenstein LM; Kagey-Sobotka A; White JM; Hamilton RG
J Immunol; 1992 Jun; 148(12):3929-36. PubMed ID: 1376345
[TBL] [Abstract][Full Text] [Related]
24. Regulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumab.
Zaidi AK; Saini SS; Macglashan DW
J Allergy Clin Immunol; 2010 Apr; 125(4):902-908.e7. PubMed ID: 20236696
[TBL] [Abstract][Full Text] [Related]
25. Isotypic analysis of grass pollen-specific antibodies in human plasma. 4. Biological activity of allergen-specific and autoanti-IgE antibody fractions on basophil histamine release.
Batard T; Weyer A; Laroze A; Ickovic MR; David B; Peltre G; Basuyaux B
Clin Exp Allergy; 1996 Nov; 26(11):1308-15. PubMed ID: 8955580
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo.
Saini SS; MacGlashan DW; Sterbinsky SA; Togias A; Adelman DC; Lichtenstein LM; Bochner BS
J Immunol; 1999 May; 162(9):5624-30. PubMed ID: 10228046
[TBL] [Abstract][Full Text] [Related]
27. Human basophil activation measured by CD63 expression and LTC4 release in IgE-mediated food allergy.
Moneret-Vautrin DA; Sainte-Laudy J; Kanny G; Frémont S
Ann Allergy Asthma Immunol; 1999 Jan; 82(1):33-40. PubMed ID: 9988204
[TBL] [Abstract][Full Text] [Related]
28. Sensitization of skin mast cells with IgE antibodies to Culicoides allergens occurs frequently in clinically healthy horses.
Wagner B; Miller WH; Erb HN; Lunn DP; Antczak DF
Vet Immunol Immunopathol; 2009 Nov; 132(1):53-61. PubMed ID: 19836083
[TBL] [Abstract][Full Text] [Related]
29. The stripped basophil histamine release bioassay as a tool for the detection of allergen-specific IgE in serum.
Kleine Budde I; de Heer PG; van der Zee JS; Aalberse RC
Int Arch Allergy Immunol; 2001 Dec; 126(4):277-85. PubMed ID: 11815734
[TBL] [Abstract][Full Text] [Related]
30. "Auto-anti-IgE": naturally occurring IgG anti-IgE antibodies may inhibit allergen-induced basophil activation.
Chan YC; Ramadani F; Santos AF; Pillai P; Ohm-Laursen L; Harper CE; Fang C; Dodev TS; Wu SY; Ying S; Corrigan CJ; Gould HJ
J Allergy Clin Immunol; 2014 Dec; 134(6):1394-1401.e4. PubMed ID: 25112697
[TBL] [Abstract][Full Text] [Related]
31. The effect of bacterial lipopolysaccharide (LPS) on histamine release from human basophils. I. Enhancement of immunologic release by LPS.
Smith TF; Aelvoet M; Morrison DC
Clin Immunol Immunopathol; 1985 Mar; 34(3):355-65. PubMed ID: 2578909
[TBL] [Abstract][Full Text] [Related]
32. Basophil mediator release in atopic dermatitis.
Bull HA; Courtney PF; Bunker CB; Rustin MH; Pearce FL; Dowd PM
J Invest Dermatol; 1993 Mar; 100(3):305-9. PubMed ID: 7680056
[TBL] [Abstract][Full Text] [Related]
33. Effect of allergen-specific immunotherapy on recombinant human interleukin 3-mediated amplification of allergen-induced basophil histamine release.
Kowal K; Nolte H; Skov PS; DuBuske LM
Allergy Asthma Proc; 2005; 26(6):456-62. PubMed ID: 16541969
[TBL] [Abstract][Full Text] [Related]
34. Allergen- and anti-IgE-induced histamine release from whole blood.
Tanizaki Y; Komagoe H; Morinaga H; Kitani H; Goda Y; Kimura I
Int Arch Allergy Appl Immunol; 1984; 73(2):141-5. PubMed ID: 6198291
[TBL] [Abstract][Full Text] [Related]
35. Omalizumab-induced reductions in mast cell Fce psilon RI expression and function.
Beck LA; Marcotte GV; MacGlashan D; Togias A; Saini S
J Allergy Clin Immunol; 2004 Sep; 114(3):527-30. PubMed ID: 15356552
[TBL] [Abstract][Full Text] [Related]
36. Omalizumab may not inhibit mast cell and basophil activation in vitro.
Gericke J; Ohanyan T; Church MK; Maurer M; Metz M
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1832-6. PubMed ID: 25257818
[TBL] [Abstract][Full Text] [Related]
37. Defective inhibition of sodium on basophil histamine release in patients with allergic rhinitis and bronchial asthma.
Tedeschi A; Cottini M; Salmaso C; Milazzo N; Miadonna A
Eur Respir J; 1996 Oct; 9(10):2070-6. PubMed ID: 8902469
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects.
Arm JP; Bottoli I; Skerjanec A; Floch D; Groenewegen A; Maahs S; Owen CE; Jones I; Lowe PJ
Clin Exp Allergy; 2014 Nov; 44(11):1371-85. PubMed ID: 25200415
[TBL] [Abstract][Full Text] [Related]
39. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables.
MacGlashan DW
J Allergy Clin Immunol; 1993 Feb; 91(2):605-15. PubMed ID: 7679683
[TBL] [Abstract][Full Text] [Related]
40. Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability.
Shim JY; Kim BS; Cho SH; Min KU; Hong SJ
Clin Exp Allergy; 2003 Jan; 33(1):52-7. PubMed ID: 12534549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
